How Can the Pharma Industry Leverage the Patient Journey to Drive Transformative Innovation?

/in /by

The growing proliferation of generic drugs has intensified pharma industry competition for both physician and patient brand loyalty. In a sea of increasing “sameness” – the delivery device – not the commoditized drug is fast becoming the most meaningful point of differentiation among pharmaceutical companies.

LinkedIn pharma post

Take for example, cases of self-drug administration by those with special cognitive or physical limitations, such as autoimmune disease. The patient’s ease-of-use and favorable experience with a strategically-designed drug delivery device not only increases their prescription refill adherence and device loyalty, but also drives physicians’ confidence level in the brand and, ultimately – higher volume prescription rates.

To receive a digital copy of the full article, or a full size high-resolution poster of The Patient Journey please fill out the form below:

  • This form collects your name and email so that we can send you your requested content. Check out our privacy policy for more details on how we protect and manage your submitted data.
  • This field is for validation purposes and should be left unchanged.

 

 

 

Transformative Innovation in Drug Delivery via the Patient Journey Patient Journey Drug Deliver OnDrugDelivery What Fuels Smarter Drug Delivery Device Design?